| Device |
automated insulin dosing device system, single hormonal control |
| Definition |
An insulin-only automated insulin dosing system that achieves a target glucose level by automatically increasing or reducing insulin infusion from an insulin pump. Insulin adjustments are based upon specified thresholds of measured glucose levels. |
| Physical State |
May include: Continuous glucose monitoring system, sensor, self monitoring blood glucose device, infusion pump, data management software |
| Technical Method |
Uses a glucose monitoring system to measure glucose levels and increases or reduces insulin infusion from an insulin pump |
| Target Area |
Not meant to act on a specific part of the body but works with other devices - Continuous glucose monitoring system, sensor, self monitoring blood glucose device, data management software |
| Review Panel |
Clinical Chemistry |
| Product Code | OZP |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Chemistry and Toxicology Devices
(DCTD)
|
| Submission Type |
PMA
|
| Device Class |
3
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Recognized Consensus Standards
|
| Third Party Review |
Not Third Party Eligible |